Projects per year
Fingerprint
Dive into the research topics where Matthew Philip Goetz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 22 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Mayo Clinic Breast Cancer SPORE
Vachon, C. M., Suman, V. J., Lingle, W. L., Couch, F. J., Chen, J., Goetz, M. P., Visscher, D. W., Hawse, J. R. & Galanis, E.
7/1/05 → 8/31/21
Project: Research project
-
Tamoxifen biotransformation pathway pharmacogenomics
Goetz, M. P. & Kinney, L.
7/11/08 → 11/30/14
Project: Research project
Research Output
-
Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3
Rugo, H. S., Huober, J., García-Sáenz, J. A., Masuda, N., Sohn, J. H., Andre, V. A. M., Barriga, S., Cox, J. & Goetz, M., Jan 2021, In: Oncologist. 26, 1, p. e53-e65Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor
Ingle, J. N., Cairns, J., Suman, V. J., Shepherd, L. E., Fasching, P. A., Hoskin, T. L., Singh, R. J., Desta, Z., Kalari, K. R., Ellis, M. J., Goss, P. E., Chen, B. E., Volz, B., Barman, P., Carlson, E. E., Haddad, T., Goetz, M. P., Goodnature, B., Cuellar, M. E., Walters, M. A. & 4 others, , Jun 15 2020, In: Clinical Cancer Research. 26, 12, p. 2986-2996 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Jayaraman, S., Hou, X., Kuffel, M. J., Suman, V. J., Hoskin, T. L., Reinicke, K. E., Monroe, D. G., Kalari, K. R., Tang, X., Zeldenrust, M. A., Cheng, J., Bruinsma, E. S., Buhrow, S. A., McGovern, R. M., Safgren, S. L., Walden, C. A., Carter, J. M., Reid, J. M., Ingle, J. N., Ames, M. M. & 2 others, , May 19 2020, In: Breast Cancer Research. 22, 1, 51.Research output: Contribution to journal › Article › peer-review
Open Access -
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In: npj Breast Cancer. 6, 1, 15.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
A transcriptionally definable subgroup of triple-negative breast and ovarian cancer samples shows sensitivity to Hsp90 inhibition
Shee, K., Wells, J. D., Ung, M., Hampsch, R. A., Traphagen, N. A., Yang, W., Liu, S. C., Zeldenrust, M. A., Wang, L., Kalari, K. R., Yu, J., Boughey, J. C., Demidenko, E., Kettenbach, A. N., Cheng, C., Goetz, M. P. & Miller, T. W., Jan 1 2020, In: Clinical Cancer Research. 26, 1, p. 159-170 12 p.Research output: Contribution to journal › Article › peer-review